Arcellx, Inc. Common Stock
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ACLX Smart Score
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Show Less
Recent trades of ACLX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ACLX's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to ACLX
Recent picks made for ACLX stock on CNBC
ETFs with the largest estimated holdings in ACLX
Flights by private jets registered to ACLX